Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis has demonstrated benefits of an investigational, once-a-day pill called brenso catib as ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published ...

Results of a large clinical trial demonstrated the benefits of an investigational, once-a-day pill called brenso­catib as a ...

Symptoms of bronchiectasis include chronic cough with sputum (mucous) production, shortness of breath and fatigue. Acute exacerbations of the debilitating condition experienced by patients are ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue ...

In addition, enrollment is ongoing in our Phase II clinical trial of nebulized Ensifentrine in non-CF bronchiectasis ... on the rate and risk of pulmonary exacerbations, symptoms and quality ...

A new meta-analysis shows point-of-care testing reduces unnecessary antibiotics in patients experiencing COPD exacerbations, ...